These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 25218177)
1. Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors. Chong CR; Wirth LJ; Nishino M; Chen AB; Sholl LM; Kulke MH; McNamee CJ; Jänne PA; Johnson BE Lung Cancer; 2014 Nov; 86(2):241-6. PubMed ID: 25218177 [TBL] [Abstract][Full Text] [Related]
2. Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report. Forde PM; Hooker CM; Boikos SA; Petrini I; Giaccone G; Rudin CM; Yang SC; Illei PB; Hann CL; Ettinger DS; Brahmer JR; Kelly RJ J Thorac Oncol; 2014 Mar; 9(3):414-8. PubMed ID: 24518093 [TBL] [Abstract][Full Text] [Related]
3. Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid. Wang X; Li Y; Duan J; Chen Y; Yuan B; Qi Z; Tan H Oncologist; 2019 Jun; 24(6):798-802. PubMed ID: 30413666 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors. Walter T; Planchard D; Bouledrak K; Scoazec JY; Souquet PJ; Dussol AS; Guigay J; Hervieu V; Berdelou A; Ducreux M; Arpin D; Lombard-Bohas C; Baudin E Lung Cancer; 2016 Jun; 96():68-73. PubMed ID: 27133753 [TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy. Wirth LJ; Carter MR; Jänne PA; Johnson BE Lung Cancer; 2004 May; 44(2):213-20. PubMed ID: 15084386 [TBL] [Abstract][Full Text] [Related]
6. Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience. Herde RF; Kokeny KE; Reddy CB; Akerley WL; Hu N; Boltax JP; Hitchcock YJ Am J Clin Oncol; 2018 Jan; 41(1):24-29. PubMed ID: 26270444 [TBL] [Abstract][Full Text] [Related]
7. Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours. Papaxoinis G; Kordatou Z; McCallum L; Nasralla M; Lamarca A; Backen A; Nonaka D; Mansoor W Neuroendocrinology; 2020; 110(5):413-421. PubMed ID: 31437838 [TBL] [Abstract][Full Text] [Related]
8. Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs. Lenotti E; Alberti A; Spada F; Amoroso V; Maisonneuve P; Grisanti S; Baggi A; Bianchi S; Fazio N; Berruti A Front Endocrinol (Lausanne); 2021; 12():669484. PubMed ID: 33986731 [TBL] [Abstract][Full Text] [Related]
9. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors]. Correia Sda S; Pinto C; Bernardo J Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary carcinoid tumours: indolent but not benign. De Dosso S; Bajetta E; Procopio G; Cortinovis D; Buzzoni R; Catena L; Platania M; Verzoni E Oncology; 2007; 73(3-4):162-8. PubMed ID: 18418008 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD; Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366 [TBL] [Abstract][Full Text] [Related]
13. Experience in treatment of metastatic pulmonary carcinoid tumors. Granberg D; Eriksson B; Wilander E; Grimfjärd P; Fjällskog ML; Oberg K; Skogseid B Ann Oncol; 2001 Oct; 12(10):1383-91. PubMed ID: 11762808 [TBL] [Abstract][Full Text] [Related]
14. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement. Thomas CF; Tazelaar HD; Jett JR Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial. Ferolla P; Brizzi MP; Meyer T; Mansoor W; Mazieres J; Do Cao C; Léna H; Berruti A; Damiano V; Buikhuisen W; Grønbæk H; Lombard-Bohas C; Grohé C; Minotti V; Tiseo M; De Castro J; Reed N; Gislimberti G; Singh N; Stankovic M; Öberg K; Baudin E Lancet Oncol; 2017 Dec; 18(12):1652-1664. PubMed ID: 29074099 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. Anderson KL; Mulvihill MS; Speicher PJ; Yerokun BA; Gulack BC; Nussbaum DP; Harpole DH; D'Amico TA; Berry MF; Hartwig MG Ann Thorac Surg; 2017 Oct; 104(4):1221-1230. PubMed ID: 28760471 [TBL] [Abstract][Full Text] [Related]
17. Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of Bongiovanni A; Recine F; Riva N; Foca F; Liverani C; Mercatali L; Nicolini S; Pieri F; Amadori D; Ibrahim T Clin Lung Cancer; 2017 Jul; 18(4):415-420. PubMed ID: 27956089 [TBL] [Abstract][Full Text] [Related]
18. Carcinoid tumors of the lung: a report of 11 cases. Ichiki Y; Nagashima A; Yasuda M; Takenoyama M Asian J Surg; 2013 Jul; 36(3):116-20. PubMed ID: 23810161 [TBL] [Abstract][Full Text] [Related]
19. A phase II study of docetaxel in patients with metastatic carcinoid tumors. Kulke MH; Kim H; Stuart K; Clark JW; Ryan DP; Vincitore M; Mayer RJ; Fuchs CS Cancer Invest; 2004; 22(3):353-9. PubMed ID: 15493355 [TBL] [Abstract][Full Text] [Related]
20. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors. Walts AE; Ines D; Marchevsky AM Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]